+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 30Years - 74Years
FEMALE
Healthy Volunteers
ID02620852

Personalized Versus Annual Breast Cancer Screening Based on Individual Risk Factors with Self-Selection Option

Led by University of California, San Francisco · Updated on 2026-09-21

100000

Participants Needed

11

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new approach to breast cancer screening that personalizes recommendations based on individual risk factors rather than the traditional one-size-fits-all annual mammogram starting at age 40. This study compares annual screening to a risk-based schedule that considers personal and family history, breast density, and genetic testing. The goal is to reduce false positives, unnecessary biopsies, and overdiagnosis while maintaining early cancer detection. The study includes women ages 30 to 74, with those aged 30 to 39 only eligible for the personalized screening arm. Participants are assigned to one of two groups the Annual Arm, which follows standard annual mammograms and basic risk assessment, or the Risk-Based Arm, which involves a comprehensive risk assessment including genetic testing of nine genes and a panel of SNPs to tailor screening frequency, start, and stop dates. All participants complete health questionnaires and receive screening advice based on their assigned risk assessment method. Notably, the study allows participants to choose their screening arm rather than being randomized. During the study, participants provide saliva samples for genetic testing and complete questionnaires. Researchers will monitor outcomes such as late-stage cancer rates and biopsy rates over at least five years. Additional measures include breast imaging rates, cancer anxiety, and adherence to screening schedules. The study aims to provide personalized screening schedules that optimize benefits and reduce harms. Participation may last up to ten years, with ongoing data collection to evaluate long-term effects and screening safety.

CONDITIONS

Brief Title

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Research Team

A

Allison Fiscalini, MPH

J

Jennifer Atamer

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here